Hypertriglyceridaemic waist phenotype and β-cell function in subjects with normal and impaired glucose tolerance

Diabetic Medicine

Volumn 28, Issue 10, 2011, Pages 1229-1233

  Bardini, G ^a   Dicembrini, I ^a   Pala, L ^a   Cresci, B ^a   Rotella, C M ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

Author keywords

cell dysfunction; Homeostasis model assessment2 index; Hypertriglyceridaemic waist phenotype

Indexed keywords

GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE; HOMEOSTASIS; HUMAN; HYPERTRIGLYCERIDEMIA; IMPAIRED GLUCOSE TOLERANCE; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; ORAL GLUCOSE TOLERANCE TEST; PANCREAS ISLET BETA CELL; PANCREAS ISLET CELL FUNCTION; WAIST CIRCUMFERENCE;

ADULT; BIOLOGICAL MARKERS; BLOOD GLUCOSE; BODY MASS INDEX; CHOLESTEROL, HDL; CHOLESTEROL, LDL; DIABETES MELLITUS, TYPE 2; DIABETIC ANGIOPATHIES; FEMALE; GLUCOSE INTOLERANCE; HUMANS; HYPERTRIGLYCERIDEMIA; INSULIN RESISTANCE; INSULIN-SECRETING CELLS; MALE; MIDDLE AGED; ODDS RATIO; PHENOTYPE; RISK FACTORS; TRIGLYCERIDES; WAIST CIRCUMFERENCE;

EID: 80053012496     PISSN: 07423071     EISSN: 14645491     Source Type: Journal    
DOI: 10.1111/j.1464-5491.2011.03332.x     Document Type: Article

References (23)

1. Kahn SE, Hull RL, Utzschneider KM. Mechanisms linking obesity to insulin resistance and type 2 diabetes. Nature 2006; 444: 840-846.
2. Nathan DM, Davidson MB, DeFronzo RA, Heine RJ, Henry RR, Pratley R et al.; American Diabetes Association Impaired fasting glucose and impaired glucose tolerance: implications for care. Diabetes Care 2007; 30: 753-759.
3. Carr DB, Utzschneider KM, Hull RL, Kodama K, Retzlaff BM, Brunzell JD et al. Intra-abdominal fat is a major determinant of the National Cholesterol Education Program Adult Treatment PanelIII criteria for the metabolic syndrome. Diabetes 2004; 53: 2087-2094.
4. Lemieux I, Pascot A, Couillard C, Lamarche B, Tchernof A, Alméras N et al. Hypertriglyceridemic waist: a marker of the atherogenic metabolic triad (hyperinsulinemia; hyperapolipoproteinB; small, dense LDL) in men? Circulation 2000; 102: 179-184.
5. Lemieux I, Alméras N, Mauriège P, Blanchet C, Dewailly E, Bergeron J et al. Prevalence of 'hypertriglyceridemic waist' in men who participated in the Quebec Health Survey: association with atherogenic and diabetogenic metabolic risk factors. Can J Cardiol 2002; 18: 725-732.
6. St-Pierre J, Lemieux I, Vohl MC, Perron P, Tremblay G, Després JP et al. Contribution of abdominal obesity and hypertriglyceridemia to impaired fasting glucose and coronary artery disease. Am J Cardiol 2002; 90: 15-18.
7. Sam S, Haffner S, Davidson MH, D'Agostino RB Sr, Feinstein S, Kondos G et al. Hypertriglyceridemic waist phenotype predicts increased visceral fat in subjects with type2 diabetes. Diabetes Care 2009; 32: 1916-1920.
8. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972; 18: 499-502.
9. Wallace TM, Levy JC, Matthews DR. Use and abuse of HOMA modelling. Diabetes Care 2004; 27: 1487-1495.
10. Expert Committee on the Diagnosis and Classification of Diabetes Mellitus: Follow-up report on the diagnosis of diabetes mellitus. Diabetes Care 2003; 26: 3160-3167.
11. Rasmussen SS, Glümer C, Sandbaek A, Lauritzen T, Borch-Johnsen K. Determinants of progression from impaired fasting glucose and impaired glucose tolerance to diabetes in a high-risk screened population: 3-year follow-up in the ADDITION study, Denmark. Diabetologia 2008; 51: 249-257.
12. Bergman RN, Ader M. Free fatty acids and pathogenesis of type2 diabetes mellitus. Trends Endocrinol Metab 2000; 11: 351-356.
13. Unger RH, Zhou YT. Lipotoxicity of beta-cells in obesity and in other causes of fatty acid spillover. Diabetes 2001; 50: S118-S121.
14. Dubois M, Kerr-Conte J, Gmyr V, Bouckenooghe T, Muharram G, D'Herbomez M et al. Non-esterified fatty acids are deleterious for human pancreatic islet function at physiological glucose concentration. Diabetologia 2004; 47: 463-469.
15. Kashyap S, Belfort R, Gastaldelli A, Pratipanawatr T, Berria R, Pratipanawatr W et al. A sustained increase in plasma free fatty acids impairs insulin secretion in non-diabetic subjects genetically predisposed to develop type2 diabetes. Diabetes 2003; 52: 2461-2474.
16. DeFronzo RA. Insulin resistance, lipotoxicity, type2 diabetes and atherosclerosis: the missing links. The Claude Bernard Lecture 2009. Diabetologia 2010; 53: 1270-1287.
17. Katsuki A, Sumida Y, Urakawa H, Gabazza EC, Murashima S, Maruyama N et al. Increased visceral fat and serum levels of triglyceride are associated with insulin resistance in Japanese metabolically obese, normal weight subjects with normal glucose tolerance. Diabetes Care 2003; 26: 2341-2344.
18. Rogowski O, Shapira I, Steinvil A, Berliner S. Low-grade inflammation in individuals with the hypertriglyceridemic waist phenotype: another feature of the atherogenic dysmetabolism. Metabolism 2009; 58: 661-667.
19. Blackburn P, Lemieux I, Alméras N, Bergeron J, Côté M, Tremblay A et al. The hypertriglyceridemic waist phenotype versus the National Cholesterol Education Program-Adult Treatment PanelIII and International Diabetes Federation clinical criteria to identify high-risk men with an altered cardiometabolic risk profile. Metabolism 2009; 58: 1123-1130.
20. Gastaldelli A, Sironi AM, Ciociaro D, Postano V, Buzzigoli E, Riannessi D et al. Visceral fat and beta-cell function in non-diabetic humans. Diabetologia 2005; 48: 2090-2096.
21. Hanley AJ, Wagenknecht LE, Norris JM, Bryer-Ash M, Chen YI, Anderson AM et al. Insulin resistance, beta-cell dysfunction and visceral adiposity as predictors of incident diabetes: the Insulin Resistance Atherosclerosis Study (IRAS) Family study. Diabetologia 2009; 52: 2079-2086.
22. Wagenknecht LE, Langefeld CD, Scherzinger AL, Norris JM, Haffner SM, Saad MF et al. Insulin sensitivity, insulin secretion and abdominal fat. The Insulin Resistance Atherosclerosis Study (IRAS) family study. Diabetes 2003; 52: 2490-2496.
23. Utzschneider KM, Carr DB, Hull RL, Kodama K, Shofer JB, Retzlaff BM et al. Impact of intra-abdominal fat and age on insulin sensitivity and beta-cell function. Diabetes 2004; 53: 2867-2872.